• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • FDA announces expansion of generic impurity investigation europeanpharmaceuticalreview
    September 02, 2019
    The examination of ARB drugs by the FDA will be extended to include other generics with similar manufacturing processes to identify impurities.
  • Impurity in valsartan leads to voluntary recall europeanpharmaceuticalreview
    August 07, 2018
    Healthcare professionals and patients have been alerted by the U.S. Food and Drug Administration (FDA) of a voluntary recall of drugs containing the active ingredient valsartan. This active ingredient is used in drugs to treat high blood pressure and hear

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service